A former University of Toledo medical fellow has been sentenced to prison for setting a house on fire in December, our CBS affiliate WTOL-11 TV reported. Andrew Campbell, 34, was sentenced to four to ...

Stephen Miran, President Donald Trump's nominee for the Federal Reserve Board of Governors, could be confirmed in time to take part in the mid-September rate-setting meeting. Fed watchers broadly ...

Fall is around the corner, which means the end of this year's daylight saving time is coming up. In November, millions of Americans will turn back their clocks, marking the end of daylight saving time ...

Six years and one legendary hype cycle later, it's finally time for Hollow Knight: Silksong, the follow-up to Team Cherry's beloved 2017 Metroidvania. Yes, it's hard to believe we'll soon be living in ...

Twilight fans will soon be able to relive their Team Edward vs. Team Jacob days in the theater, as the hit franchise is set to be re-released in time for hoa-hoa-hoa season (autumn). Starting October ...

Alphabet will avoid having to sell its Google Chrome browser. Alphabet's business is growing rapidly. The stock still trades at a discount to its peers. However, I think that's a mistake. There's a ...

Indie publisher Critical Reflex announced today that, in anticipation of several of its titles releasing in a couple of weeks, it will be doing its own “unhinged” showcase called “Critical Reflex Time ...

The iPhone's alarm is a feature we've been taking for granted for nearly twenty years. It's a basic feature of the Clock app that allows users to set an alarm (or multiple) and wait for the iPhone to ...

The United States could see its population shrink for the first time ever in 2025 as immigration numbers and birth rates have plummeted, according to a report. Net international migration to the US in ...

WWE superstars are set to clash at the Clash in Paris premium live event on Sunday, Aug. 31, at the Paris La Défense Arena in Nanterre, France. It’s the first major show since the first-ever two-day ...

COPENHAGEN, Denmark, September 03, 2025--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced updated results from the Phase 2 EPCORE ® NHL-6 trial (NCT05451810) evaluating the safety and ...